Treatment of unresectable hepatocellular carcinoma with Adriamycin: potentiation of tumoricidal effect by Verapamil
Dr Lai, Edward Cheuck Seen (Principal investigator)
Dr Choi Tat Kuen (Co-Investigator)
Lee Wing Tat Fund
To verify the enhanced anti-tumor effect clinically in cirrhotic Chinese patients with HCC by the addition of VER at the proposed dosage of systemic Adriamycin; to identify the toxic profile of VER + Adriamycin regimen in such patients and determine whether it is predictable, tolerable and reversible.